14-day Premium Trial Subscription Try For FreeTry Free

Nautilus Biotechnology, Inc. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 98.79. In total, the insiders bought 21 630 038 and sold 214 635 NAUT shares in the last 100 trades.

Insider Power

(Last 100 transactions)
98.79
Buy 21 630 038 Shares
Sell 214 635 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 14, 2024 Stock Option (Right to Buy) Buy Mcilwain Matthew S 45 000
Jun 14, 2024 Stock Option (Right to Buy) Buy Altman Michael Seth 45 000
Jun 14, 2024 Stock Option (Right to Buy) Buy Perceptive Advisors Llc 45 000
Jun 14, 2024 Stock Option (Right to Buy) Buy Akinsanya Karen 45 000
Jun 14, 2024 Stock Option (Right to Buy) Buy Epperly Melissa B, 45 000
Jun 14, 2024 Stock Option (Right to Buy) Buy Pande Vijay Satyanand 45 000
Jun 14, 2024 Stock Option (Right to Buy) Buy Nazem Farzad 45 000
Jun 14, 2024 Stock Option (Right to Buy) Buy Posard Matthew L. 45 000
Mar 11, 2024 Common Stock Buy Patel Sujal M 12 044
Mar 08, 2024 Common Stock Buy Patel Sujal M 2 430
Mar 07, 2024 Common Stock Buy Patel Sujal M 18 854
Mar 06, 2024 Common Stock Buy Patel Sujal M 9 267
Mar 05, 2024 Common Stock Buy Patel Sujal M 7 405
Mar 01, 2024 Stock Option (Right to Buy) Buy Patel Sujal M 650 000
Mar 01, 2024 Stock Option (Right to Buy) Buy Mallick Parag 280 000
Mar 01, 2024 Stock Option (Right to Buy) Buy Nelson Nicholas A. 160 000
Mar 01, 2024 Stock Option (Right to Buy) Buy Mowry Anna 160 000
Mar 01, 2024 Stock Option (Right to Buy) Buy Weld Gwen E 160 000
Mar 01, 2024 Stock Option (Right to Buy) Buy Murphy Matthew B. 160 000
Mar 01, 2024 Stock Option (Right to Buy) Buy Sankar Subramanian 160 000
Mar 01, 2024 Stock Option (Right to Buy) Buy Godwin Mary E. 160 000
Jun 15, 2023 Stock Option (Right to Buy) Buy Perceptive Advisors Llc 45 000
Jun 15, 2023 Stock Option (Right to Buy) Buy Altman Michael Seth 45 000
Jun 15, 2023 Stock Option (Right to Buy) Buy Mcilwain Matthew S 45 000
Jun 15, 2023 Stock Option (Right to Buy) Buy Posard Matthew L. 45 000
Click to get the best stock tips daily for free!

About Nautilus Biotechnology, Inc.

Nautilus Biotechnology. Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.... NAUT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT